Cidara Therapeutics (CDTX) said Thursday it has agreed to a private placement expected to raise about $105 million.
Under the agreement, Cidara will issue about 3.9 million shares of common stock at $14.912 per share, the company said. Additionally, certain investors will purchase about 3.2 million pre-funded warrants at $14.9119 each, with an exercise price of $0.0001 per warrant, the company added.
The company said the financing, led by Venrock Healthcare Capital Partners, includes participation from new and existing investors like RA Capital Management among others.
Net proceeds from the placement, expected to close by Nov. 25, will be used to advance research and development, support working capital needs, and cover general corporate expenses, Cidara said.
Shares of the company were up 25% in early Wednesday trading.
Price: 18.86, Change: +3.74, Percent Change: +24.75
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.